PBS funding for MHT patches 'at risk', doctors say
Transdermal patches could be pulled from the PBS if the manufacturer's bid for a price hike is declined
Women’s health advocates are fighting to keep several menopausal hormone therapy products on the PBS — including the only two remaining combined transdermal patches — after a bid to delist them.
Dr Karen Magraith.
The supplier of Estradot (oestradiol) and Estalis (oestradiol and norethisterone), Sandoz (a division of Novartis), applied to the PBAC
